Taiwan FDA warns against honey drink found to contain methoxsalen

Taiwan's Food and Drug Administration (FDA) said Friday that buyers of Atomy Corp.'s HemoHIM honey drink should stop using it after it was found to contain methoxsalen, a medication that potentially causes liver damage.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)